Oncolytics Biotech (ONCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BRIACELL THERAP (BCTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

Compass Therapeutics, Inc. (CMPX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Why has the Bank of England cut the base rate? At the first opportunity this year, the base rate has been reduced by 0.25 ...

“Product of Canada” applies when a food product’s primary ingredients, processing and associated labour are Canadian. The minor use of ingredients not typically grown or produced in Canada, such as ...

You'll need to submit tax updates every three months' Mike Croxford, Which? Money expert, says... Making Tax Digital requires ...

Suggestion that the US take over and redevelop the war-torn region, and displace its Palestinian residents, has been condemned by Arab allies but welcomed by Israel ...

Tariffs on Canadian goods may be delayed for now, but what does the looming threat of a trade war mean for homebuyers?

Donald Trump signs Executive Order establishing the Sovereign Wealth Fund, which could profit from, and potentially purchase, ...